Ming Gao

4PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 13, 2024
An Artificial Intelligence-Driven Preoperative Radiomic Subtype for Predicting the Prognosis and Treatment Response of Patients with Papillary Thyroid Carcinoma.

Qiang Li, Weituo Zhang, Tian Liao

|Jan 23, 2024
Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patients.

Xiangqian Zheng, Meiyu Fang, Yun Fan

|Aug 18, 2023
Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial.

Yihebali Chi, Xiangqian Zheng, Yuan Zhang

|Jul 30, 2021
A Randomized, Phase III Study of Lenvatinib in Chinese Patients with Radioiodine-Refractory Differentiated Thyroid Cancer.

Xiangqian Zheng, Zhengang Xu, Qinghai Ji

Pageof 1